A Proven Track Record

Defective Stryker Hip Settlement

Schwarz Mongeluzzi Law attorneys were directly involved with a recent global settlement program involving Stryker Orthopaedics’ Rejuvenate and ABGII modular hip implants. These defective devices were recalled in 2012, after being implanted in tens of thousands of patients. Settlement payments for 4000 potential claimants, including healthcare reimbursements, are expected to exceed $1 billion. However, this settlement represents compensation for a mere 20% of failed devices. Expenses related to these devices have and will largely be borne by healthcare payers, which have and will pay an estimated $900 million in connection with these Stryker hips alone.

Prempro Hormone Replacement

Our attorneys have secured several hard-fought verdicts against drug makers in connection with hormone replacement drugs Premaprin, Provera, and Prempro. In these cases, patients alleged that Pfizer failed to conduct studies on the long-term effects of the drugs, and downplayed reports of cancer links in an effort to continue marketing them. According to Schwarz Mongeluzzi attorney Toby Millrood, “the company [told doctors] that the benefits outweighed any risks, and that these drugs should be taken long term.” These were some of the first verdicts among a number of cases pending involving the drugs, which are still on the market.

Parking Garage Collapse

Robert J. Mongeluzzi secured a global settlement of $101 million following the collapse of a parking garage under construction in Atlantic City, NJ that killed or injured more than 30 workers. In preparation for trial, attorneys representing the plaintiffs took nearly 250 depositions and reviewed more than 1.5 million pages of documents. The settlement ultimately recovered more than $16 million in medical expenses—about $8.2 million of workers’ compensation payments, and more than $8.3 million in future medical expenses.